| Literature DB >> 32220335 |
Andrew Kaplan1, Sebastian A Andrei2, Anna van Regteren Altena3, Tristan Simas3, Sara L Banerjee4, Nobuo Kato5, Nicolas Bisson4, Yusuke Higuchi5, Christian Ottmann6, Alyson E Fournier7.
Abstract
Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.Entities:
Keywords: 14-3-3; Rap1; axon; polypharmacology; regeneration; spinal cord injury
Mesh:
Substances:
Year: 2020 PMID: 32220335 DOI: 10.1016/j.chembiol.2020.02.010
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116